Lorenza Bellusci, Hana Golding, and Surender Khurana Journal of Clinical Investigation Published 2023 - More infoView PDF Convalescent plasma (CP) and hyperimmune intravenous immunoglobulins (IVIGs) are routinely used to treat patients with COVID-19.…[...]
Molnupiravir was one of the first antivirals available on the market during the COVID-19 pandemic, and was employed by many countries, including the US, particularly against chronic infections. By IAN RANDALL…[...]
Carlo Brogna, Simone Cristoni, Giuliano Marino, Luigi Montano, Valentina Viduto, Mark Fabrowski, Gennaro Lettieri, Marina Piscopo, 31 August 2023 https://doi.org/10.1002/prca.202300048 Abstract Purpose The SARS-CoV-2 pandemic prompted the development and use of next-generation vaccines. Among these, mRNA-based vaccines…[...]
BY CARRIE MACMILLAN AUGUST 31, 2023 A new coronavirus variant is raising alarm, but much about it remains unknown Note: Information in this article was accurate at the time of original publication.…[...]
Wall Street Journal January 23, 2023 Wall Street Journal editorial board member Allysia Finley has taken a flamethrower to vaccine makers over their "deceptive" campaign for bivalent Covid boosters, and…[...]
Authors: David Axe September 6, 2022 The Daily Beast When the pharmaceutical industry scrambled to develop the first COVID vaccines back in 2020, it made sense that developers focused on the part of…[...]
Authors: Madison Muller August 25, 2022 Bloomberg Almost 40% of people hospitalized in the US with the Covid subvariant that circulated this spring were vaccinated and boosted, highlighting how new…[...]
Authors: Tina Reed, July 9, 2022 Axios Vitals As this summer heats up, so has the spread of the hot new version of COVID-19. Why it matters: This subvariant of Omicron called…[...]
Authors: David Axe Fri, July 8, 2022 Yahoo News When Will People Realize That COVID is Here To Stay? Live With It! The latest subvariant of the novel coronavirus to become dominant…[...]
Doctors say if you got infected with the Omicron BA.1 or BA.2 variants, your antibodies might not fully protect you against the newer BA.4 and BA.5 subvariants now spreading through…[...]